Mark Swain
2Patents
0h-index
5Co-inventors
31Inventor score
Filing activity: Dec 22, 2003 → Sep 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7476381B2 | Methods of reducing serum alanine transferase levels in a subject with hepatitis | Human Necessities | 0 | Expired |
| US11510928B2 | Use of mirtazapine in the treatment of inflammatory disorders, autoimmune disease and PBC | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.